References
- Kwon-Chung, KJ, Bennett, JE. Medical Mycology. Lea & Febiger, Philadelphia, 1992: 447–, 620–677.
- de Hoog, GS, Guarro, J, Gené, J, Figueras, MJ, (eds). Atlas of Clinical Fungi, 2nd edn., Centraalbureau voor Schimmelcultures, Utrecht, The Netherlands/Universitat Rovira i Virgili, Reus, Spain, 2000.
- Gugnani HC, Sood N, Singh B, Kakkar R. Subcutaneous phaeohyphomycosis due to Cladosporium cladosporioides. Mycoses 2000; 43: 85–87
- Romano C, Bilenchi R, Alessandrini C, Miracco C. Cutaneous phaeohyphomycosis caused by Cladosporium oxysporum. Mycoses 1999; 42: 111–116
- National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Approved standard M38-A. National Committee for Clinical Laboratory Standards, Wayne, Pa, 2002.
- McKemy JM, Morgan-Jones G. Studies in the genus Cladosporium sensu lato IV Concerning Cladosporium oxysporum, a pleurivorous, predominantly saprophytic species in warm climates. Mycotaxon 1991; 50: 397–405
- Forster RK, Rebell G, Wilson LA. Dematiaceous fungal keratitis. Clinical isolates and management. Br J Ophthalmol 1991; 59: 372–376
- Gerdsen R, Uerlichi M, de Hoog GS, Bieber T, Horre R. Sporotrichoid phaeohyphomycosis due to Alternaria infection. Br J Dermatol 2001; 145: 484–486
- Sharky PA, Graybill JR, Rinaldi MG., et al. Itraconazole treatment of phaeohyphomycosis. J Am Acad Dermatol 1990; 23: 577–586
- Sterliny JB, Heyman WR, Marlton MD. Potassium iodide in dermatology: A 13th century drug for the 21st century—uses, pharmacology, adverse effects, and contraindications. J Am Acad Dermatol 2000; 43: 691–697
- Sood N, Gugnani HC, Paliwal-Joshi A, Singh B. Sporotrichosis: Report of the first case from the State of Jarkhand, India. J Mycol Med 2004; 14: 52–53
- Gugnani HC. A review of zygomycosis due to Basidiobolus ranarum. Eur J Epidemiol 1999; 15: 923–929